FIIs hike stake in Strides Arcolab

12 Jun 2014 Evaluate

Foreign institutional investors (FIIs) have bought nearly 1 percentage of stake in pharmaceutical company -- Strides Arcolab -- through open market transactions. Goldman Sachs and Morgan Stanley have collectively purchased 626,212 equity shares representing 1.05% stake in the company in past two trading sessions. Of total, Goldman Sachs Investments Mauritius has bought 300,000 shares at Rs 626.28 per share, while Morgan Stanley Asia (Singapore) PTE purchased 326,212 shares at Rs 623.62 per share.

As on March 31, 2014, the promoters holding in the company stood at 27.67 % while Institutions and Non-Institutions held 51.95 % and 20.38 % respectively.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

 

Strides Pharma Scien Share Price

894.10 -16.35 (-1.80%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×